Violation Tracker Agency Summary Page
Agency Name:
Multistate Attorneys General Case
Penalty Total since 2000:
$111,395,268,927
Number of Records:
680
Note:
The penalty total above and the parent totals below include some cases in which both a state and a federal agency were involved and issued separate announcements of the outcome. The individual penalty records below marked by an asterisk are ones for which Violation Tracker contains a separate federal entry.
| Top 10 Parent Companies | Total Penalty $ | Number of Records |
|---|---|---|
| Bank of America | $26,114,848,408 | 10 |
| UBS | $11,393,380,000 | 5 |
| Citigroup | $8,235,591,577 | 7 |
| JPMorgan Chase | $6,208,338,661 | 10 |
| BP | $4,910,000,000 | 2 |
| American Electric Power | $4,687,500,000 | 3 |
| Morgan Stanley | $4,060,100,000 | 4 |
| Goldman Sachs | $3,690,833,333 | 3 |
| Deutsche Bank | $3,648,333,333 | 3 |
| Wells Fargo | $1,872,683,716 | 8 |
Individual Penalty Records:
Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
| Company | Parent | Parent Major Industry | Primary Offense Type |
Year |
Penalty Amount |
|---|---|---|---|---|---|
| Ally Financial | Ally Financial | financial services | mortgage abuses | 2012 | (*) $109,628,425 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $612,000,000 |
| AU Optronics Corporation | AU Optronics | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | $170,000,000 |
| Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | $1,650,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2012 | $2,430,000,000 |
| Bank of America | Bank of America | financial services | mortgage abuses | 2012 | (*) $2,382,415,075 |
| BioScrip, Inc. | Option Care Health | healthcare services | False Claims Act and related | 2012 | $5,000,000 |
| Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $95,000,000 |
| Citigroup | Citigroup | financial services | mortgage abuses | 2012 | (*) $413,041,577 |
| Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | (*) $11,000,000 |
| E*Trade | Morgan Stanley | financial services | price-fixing or anti-competitive practices | 2012 | $100,000 |
| Ferring B.V. | price-fixing or anti-competitive practices | 2012 | $1,800,000 | ||
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $477,792,391 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2012 | $90,000,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $181,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | mortgage abuses | 2012 | (*) $1,121,188,661 |
| KV Pharmaceutical Company | KV Pharmaceutical | pharmaceuticals | False Claims Act and related | 2012 | (*) $17,000,000 |
| LG Display Co., Ltd. | LG | diversified | price-fixing or anti-competitive practices | 2012 | $380,000,000 |
| McKesson Corporation | McKesson | wholesalers | False Claims Act and related | 2012 | $151,000,000 |
| Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*) $201,975,000 |
| MetLife | MetLife | financial services | insurance violation | 2012 | $40,000,000 |
| MOEX Offshore 2007 LLC | Mitsui | diversified | environmental violation | 2012 | (*) $25,000,000 |
| Nationwide Mutual Insurance Company | Nationwide | financial services | insurance violation | 2012 | $7,200,000 |
| NCO Financial Systems, Inc. | Alorica | business services | consumer protection violation | 2012 | $950,000 |
| Payday Loan Debt Solution, Inc. | consumer protection violation | 2012 | (*) $100,000 | ||
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $42,900,000 |
| Prudential Insurance Company of America | Prudential Financial | financial services | insurance violation | 2012 | $17,000,000 |
| QuinStreet Inc. | consumer protection violation | 2012 | $2,500,000 | ||
| Skechers USA | Skechers USA Inc. | apparel | consumer protection violation | 2012 | $5,000,000 |
| Toll Brothers Inc. | Toll Brothers | construction and engineering | environmental violation | 2012 | (*) $741,000 |
| Toshiba Corp. | Toshiba | electrical and electronic equipment | price-fixing or anti-competitive practices | 2012 | $21,000,000 |
| TradeKing | price-fixing or anti-competitive practices | 2012 | $200,000 | ||
| US Fidelis | consumer protection violation | 2012 | $13,000,000 | ||
| Walgreens | Walgreens Boots Alliance | retailing | False Claims Act and related | 2012 | (*) $600,000 |
| WellCare Health Plans Inc. | Centene | healthcare services | False Claims Act and related | 2012 | (*) $137,500,000 |
| Wells Fargo | Wells Fargo | financial services | mortgage abuses | 2012 | (*) $1,005,233,716 |
| Affinion | Apollo Global Management | private equity (including portfolio companies) | consumer protection violation | 2013 | $30,000,000 |
| American Electric Power | American Electric Power | utilities and power generation | environmental violation | 2013 | $8,500,000 |
| Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2013 | $11,000,000 |
| Ash Grove Cement Company | CRH PLC | building materials | environmental violation | 2013 | (*) $2,500,000 |
| Aviva Life & Annuity Company | Athene Holding | financial services | insurance violation | 2013 | $4,000,000 |
| Bank of America | Bank of America | financial services | investor protection violation | 2013 | $500,000,000 |
| CA Technologies | Broadcom | electrical and electronic equipment | False Claims Act and related | 2013 | $11,000,000 |
| Caremark LLC | CVS Health | retailing | False Claims Act and related | 2013 | (*) $1,940,000 |
| GenOn Power Generation, LLC | environmental violation | 2013 | $1,000,000 | ||
| Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | (*) $22,280,000 |
| Alphabet Inc. | information technology | privacy violation | 2013 | $7,000,000 | |
| Google Inc. | Alphabet Inc. | information technology | privacy violation | 2013 | $17,000,000 |
| Hachette Book Group Inc. | price-fixing or anti-competitive practices | 2013 | $34,791,666 | ||
| HarperCollins Publishers LLC | News Corp. | media | price-fixing or anti-competitive practices | 2013 | $22,471,666 |
| Healthpoint Ltd. | off-label or unapproved promotion of medical products | 2013 | (*) $28,000,000 | ||
| ING Life Insurance and Annuity Company | Voya Financial | financial services | insurance violation | 2013 | $10,700,000 |
| ISTA Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $390,253 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $541,000,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | toxic securities abuses | 2013 | (*) $1,066,000,000 |
| Kmart Corporation | Sears | retailing | False Claims Act and related | 2013 | $2,550,000 |
| Lender Processing Services, Inc. | Fidelity National Financial | financial services | mortgage abuses | 2013 | $120,000,000 |
| Lincoln National Life Insurance Company | Lincoln National | financial services | insurance violation | 2013 | $12,600,000 |
| Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2013 | (*) $3,500,000 |
| New York Life Insurance Company | New York Life Insurance | financial services | insurance violation | 2013 | $15,000,000 |
| Ocwen Financial Services | Ocwen Financial | financial services | mortgage abuses | 2013 | (*) $127,300,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $22,500,000 |
| Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | (*) $266,729,715 |
| Sanofi US Services, Inc. | Sanofi | pharmaceuticals | kickbacks and bribery | 2013 | $617,000 |
| Simon and Schuster Inc. | ViacomCBS | media | price-fixing or anti-competitive practices | 2013 | $20,641,666 |
| SunCoke Energy Inc. | SunCoke Energy | miscellaneous energy products and systems | environmental violation | 2013 | (*) $725,000 |
| Toyota Motor Company | Toyota | motor vehicles | motor vehicle safety violation | 2013 | $29,000,000 |
| Transamerica Insurance Co. | Aegon | financial services | insurance violation | 2013 | $11,200,000 |
| UBS Financial Services, Inc | UBS | financial services | investor protection violation | 2013 | $4,580,000 |
| Victory Pharma | kickbacks and bribery | 2013 | $12,200,000 | ||
| Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | (*) $257,400,000 |
| Alpha Natural Resources, Inc. | Contura Energy | mining and minerals | environmental violation | 2014 | (*) $13,750,000 |
| Apple Inc. | Apple Inc. | electrical and electronic equipment | price-fixing or anti-competitive practices | 2014 | $450,000,000 |
| Astellas Pharma US Inc. | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2014 | (*) $3,100,000 |
| AT&T Mobility LLC | AT&T | telecommunications | telecommunications violation | 2014 | (*) $20,000,000 |
| Bank of America Corporation | Bank of America | financial services | mortgage abuses | 2014 | (*) $943,000,000 |
| BioScrip, Inc. | Option Care Health | healthcare services | kickbacks and bribery | 2014 | (*) $3,310,000 |
| CareFusion | Becton Dickinson | medical equipment and supplies | off-label or unapproved promotion of medical products | 2014 | (*) $40,100,000 |
| Citigroup Inc. | Citigroup | financial services | toxic securities abuses | 2014 | (*) $291,750,000 |
| Colfax Capital Corporation and Culver Capital, LLC, also collectively known as Rome Finance | consumer protection violation | 2014 | (*) $92,000,000 | ||
| Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*) $173,000,000 |
| Extendicare Health Services Inc. | False Claims Act and related | 2014 | (*) $5,700,000 | ||
| Fortune Hi-Tech Marketing Inc. | consumer protection violation | 2014 | (*) $7,750,000 | ||
| Freedom Furniture, Inc. et al. | consumer protection violation | 2014 | (*) $2,600,000 | ||
| FreeScore360.com, FreeScoreOnline.com and ScoreSense.com | consumer protection violation | 2014 | (*) $22,000,000 | ||
| Genworth Life Insurance Co. | Genworth Financial | financial services | insurance violation | 2014 | $1,900,000 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2014 | $105,000,000 |
| Holtzbrinck Publishers LLC dba MacMillan | price-fixing or anti-competitive practices | 2014 | $26,250,000 | ||
| LSB Industries Inc. | LSB Industries | chemicals | environmental violation | 2014 | (*) $362,500 |
| Medtronic | Medtronic | medical equipment and supplies | kickbacks and bribery | 2014 | (*) $362,362 |
| Medtronic | Medtronic | medical equipment and supplies | kickbacks and bribery | 2014 | $327,000 |
| Omnicare | CVS Health | retailing | kickbacks and bribery | 2014 | (*) $4,190,000 |
| Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2014 | (*) $8,240,000 |
| Organon | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $31,000,000 |
| OtisMed Corp. | Stryker | medical equipment and supplies | False Claims Act and related | 2014 | (*) $376,700 |
| Penguin Group (USA) Inc. | Bertelsmann | media | price-fixing or anti-competitive practices | 2014 | $90,000,000 |
| Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $35,000,000 |
| Phusion Projects, LLC | consumer protection violation | 2014 | $400,000 | ||
| PointRoll, Inc. | privacy violation | 2014 | $750,000 | ||
| Shire Pharmaceuticals LLC | Takeda Pharmaceutical | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | (*) $20,786,034 |
| Sirius Radio Inc. | Sirius XM Holdings | media | consumer protection violation | 2014 | $3,800,000 |
